Partners
GENENTA Science is a spin-out from
San Raffaele Hospital
- Average >65MM€/year grants for scientific research
- 1.587 researchers, medical doctors and staff in scientific research
- >1100/year scientific papers (>10% on top tier international papers, IF>10)
- 707 clinical trials ongoing
- Best IRCCS for Scientific Research in Italy (among 47 IRCCS)
- Since 2003, best Italian Research Institute
- Since 2012, part of the Gruppo Ospedaliero San Donato 1.4B € revenues, 18 hospitals, 15,300 employees, 4million patients
San Raffaele Telethon Institute
for Gene Therapy
The San Raffaele Telethon Institute for Gene Therapy (SR-Tiget) was created in 1995 as a joint venture between the Telethon Foundation and IRCCS Ospedale San Raffaele, with the mission to perform cutting-edge research in gene and cell therapy and to translate its results into therapeutic advances, focusing on genetic diseases.
Overall, SR-Tiget represents a multi-disciplinary research environment, which provides a unique blend of scientific expertise in the development of innovative gene and cell therapy strategies, access to relevant preclinical models to evaluate their efficacy and safety, as well as competence in conducting early phase clinical trials. This provides a fertile ground for alliances with industrial partners, which possess the skills and resources required to address the regulatory hurdles and manufacturing needs to bring new therapies to registration and make them available to patients.